GlassScriptPhysician profile
Steven Nguyen
NPI 1679896104
$7,693.61
in general payments reported to CMS, 2019-2025
31 companies · $16.95 in 2025
The $16.95 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,774 · 2020: $1,168 · 2021: $2,182 · 2022: $1,180 · 2023: $102 · 2024: $271 · 2025: $16.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275 · Entertainment: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.02 |
| Entertainment | $114.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,822.68 | 2019-2020 | |
| Medtronic, INC. | $1,285.08 | 2021-2023 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $953.38 | 2019-2025 | Relistor |
| Painteq LLC | $503.50 | 2021 | |
| Boston Scientific Corporation | $439.27 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $429.06 | 2019-2022 | |
| Nalu Medical, INC. | $294.88 | 2021-2022 | |
| Abbott Laboratories | $285.65 | 2019-2020 | |
| Mdd US Operations, LLC | $271.38 | 2019-2020 | |
| Uswm, LLC | $244.73 | 2021-2022 | |
| Vertiflex, INC. | $242.32 | 2019 | |
| Vertos Medical, INC. | $142.86 | 2024 | Mild Device Kit |
| Daiichi Sankyo INC. | $134.10 | 2019 | |
| Optos, INC. | $114.67 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Scilex Pharmaceuticals INC. | $72.48 | 2019-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $72.34 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $64.05 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $51.71 | 2022 | |
| Biodelivery Sciences International, INC. | $42.91 | 2021 | |
| Almatica Pharma LLC | $35.04 | 2021 | |
| Saluda Medical Americas, INC. | $25.07 | 2023 | Evoke Scs |
| Redhill Biopharma INC. | $22.20 | 2021 | |
| Bioventus LLC | $21.46 | 2022 | |
| Forte Bio-Pharma LLC | $20.92 | 2021 | |
| Shionogi INC | $18.32 | 2019 | |
| Pacira Therapeutics, INC. | $18.11 | 2019 | |
| Spr Therapeutics, INC | $15.08 | 2021 | |
| Pernix Therapeutics Holdings, INC. | $14.68 | 2019 | |
| Zyla Life Sciences, INC. | $13.96 | 2020 | |
| Fidia Pharma USA INC. | $11.69 | 2020 | |
| Grt US Holding, INC. | $10.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.